NCT01140607 - Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Neoplasm Malignant

Interventions

DRUG

Cabazitaxel (XRP6258)

"Pharmaceutical form:solution for infusion~Route of administration: intravenous"

Trial Locations (14)

Investigational Site Number 840010, Bethlehem

Investigational Site Number 840020, Washington D.C.

Investigational Site Number 840019, Baltimore

Investigational Site Number 840016, Jacksonville

Investigational Site Number 840002, Tampa

Investigational Site Number 840021, Canton

Investigational Site Number 840017, Decatur

Investigational Site Number 840001, St Louis

Investigational Site Number 840003, Metairie

Investigational Site Number 840006, San Antonio

Investigational Site Number 840014, La Jolla

Investigational Site Number 840013, Loma Linda

Investigational Site Number 840012, Boston

Investigational Site Number 840007, Cincinnati